跳至主要内容
临床试验/NCT03234933
NCT03234933已完成不适用

Post-Operative Ambulatory Challenge and Exercise (PACE) Trial

Dana-Farber Cancer Institute1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2017年8月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
1
主要终点
Number of Steps Taken

研究概览

简要总结

This research study is evaluating the postoperative results in terms of quality of life and functional recovery of elderly patients after cancer surgery.

详细描述

This is a pilot study, designed to collect data on steps walked (ambulation) per day of lobectomy patients after surgery. While the investigators know ambulation improves outcomes after surgery, there is no institutional policy, set of patient goals, or method for deciding which patients require further resources, such as physical therapy. Data collected will be used to set up a hospital-wide strategy for patients to achieve post-operative ambulation milestones more readily.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients Aged ≥ 18 years
  • •Who underwent or who will undergo lung resection at Brigham and Women's Hospital (BWH)
  • •With diagnosis of malignant or benign disease

排除标准

  • •Patients with baseline immobility (i.e. wheelchair-bound, use of any walking assistance device, or gait alterations)
  • •Patients with cognitive deficits

研究组 & 干预措施

Mobility Tracker

Experimental
  • Each patient will be provided by the research team staff with a new mobility tracker
  • The standard pre-operative assessment, surgical procedure and post-operative care will still be done
  • Measurements of each patient (steps, distance and calories) will be obtained by the research staff

干预措施: Mobility Tracker (Other)

结局指标

主要结局

Number of Steps Taken

时间窗: 2 years

Number of steps taken by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.

次要结局

  • Distance walked(2 years)
  • Number of Calories Burned(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael T. Jaklitsch

Michael Jaklitsch, MD

Dana-Farber Cancer Institute

研究点 (1)

Loading locations...

相似试验